| 2023 | Evaluation of pharmacokinetic interactions between lobeglitazone, empagliflozin, and metformin in healthy subjects
| Translational and Clinical Pharmacology |
| 2010 | Extended-Spectrum β-Lactamase을 생성하는 Escherichia Coli 감염에 의한 패혈증 1예
| Korean Journal of Family Medicine (가정의학회지) |
| 2014 | First-in-human study with new recombinant agalsidase beta (ISU303) in healthy subjects | JOURNAL OF CLINICAL PHARMACOLOGY |
| 2013 | Functional characterization of MATE2-K genetic variants and their effects on metformin pharmacokinetics | PHARMACOGENETICS AND GENOMICS |
| 2013 | Impact of ABCC2, ABCG2 and SLCO1B1 polymorphisms on the pharmacokinetics of pitavastatin in humans
| DRUG METABOLISM AND PHARMACOKINETICS |
| 2012 | Influence of ABCC2, SLCO1B1, and ABCG2 Polymorphisms on the Pharmacokinetics of Olmesartan | JOURNAL OF CARDIOVASCULAR PHARMACOLOGY |
| 2013 | Influence of Hepatic Dysfunction on the Pharmacokinetics and Safety of Fimasartan | JOURNAL OF CARDIOVASCULAR PHARMACOLOGY |
| 2012 | Is abdominal obesity associated with the 2009 influenza A (H1N1) pandemic in Korean school-aged children? | INFLUENZA AND OTHER RESPIRATORY VIRUSES |
| 2020 | Pharmacodynamic evaluation of YH4808 for Helicobacter pylori eradication in healthy subjects
| Translational and Clinical Pharmacology |
| 2023 | Pharmacokinetic and pharmacodynamic interaction of DWP16001, a sodium-glucose cotransporter-2 inhibitor, with phentermine in healthy subjects | Expert Opinion on Drug Metabolism & Toxicology |
| 2017 | Pharmacokinetic drug interaction between atorvastatin and ezetimibe in healthy Korean volunteers
| Transl Clin Pharmacol |
| 2015 | Pharmacokinetic Interaction Between Amlodipine and Lobeglitazone, a Novel Peroxisome Proliferator–activated Receptor-γ Agonist, in Healthy Subjects | CLINICAL THERAPEUTICS |
| 2017 | Pharmacokinetic interactions between glimepiride and rosuvastatin in healthy Korean subjects: does the SLCO1B1 or CYP2C9 genetic polymorphism affect these drug interactions? Observations and introspection of the bioanalysis
| DRUG DESIGN DEVELOPMENT AND THERAPY |
| 2021 | Pharmacokinetics and safety of evogliptin in hepatically impaired patients | BRITISH JOURNAL OF CLINICAL PHARMACOLOGY |
| 2016 | Pharmacokinetics, pharmacodynamics and safety of CKD-519, a CETP inhibitor, in healthy subjects
| DRUG DESIGN DEVELOPMENT AND THERAPY |
| 2018 | Physiologically-based pharmacokinetic predictions of intestinal BCRP-mediated drug interactions of rosuvastatin in Koreans
| Korean J Physiol Pharmacol |
| 2024 | Population pharmacokinetic-pharmacodynamic modeling of clopidogrel for dose regimen optimization based on CYP2C19 phenotypes: A proof of concept study
| CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY |
| 2021 | Population Pharmacokinetics of Primaquine in the Korean Population
| PHARMACEUTICS |
| 2017 | Population pharmacokinetics of remifentanil in critically ill patients receiving extracorporeal membrane oxygenation
| SCIENTIFIC REPORTS |
| 2009 | Relationship Between Earlobe Crease and Brachial-ankle Pulse Wave Velocity in Non-hypertensive, Non-diabetic Adults in Korea
| EPIDEMIOLOGY AND HEALTH |
